Axel Gaston Glasmacher
Presidente en 4D PHARMA PLC .
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Helén Tuvesson | M | 62 | 26 años | |
| Duncan Peyton | M | 54 | 10 años | |
| Katrin Rupalla | M | 56 |
The Cancer Drug Development Forum
| 4 años |
| Alexander Stevenson | M | 53 | 10 años | |
| Andrew Schiermeier | M | 54 |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | 3 años |
| Alexander Macrae | M | 61 | 5 años | |
| Paris Panayiotopoulos | M | 50 |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | 3 años |
| Krzysztof Brzozka | M | - | 17 años | |
| Karl Peter Thelin | M | 68 | 13 años | |
| Uli Alf Hacksell | M | 74 | 5 años | |
| Michael Shalmi | M | 59 | 5 años | |
| Aleksandar Danilovski | M | 50 | 4 años | |
| Paul Maier | M | 76 | 3 años | |
| Edgardo Baracchini | M | 64 | 5 años | |
| Hans Kolam | M | 73 | 24 años | |
| Pawel Przewiezlikowski | M | - | 17 años | |
| Hendrik Nogai | M | - | 2 años | |
| Erik Vahtola | M | - | 2 años | |
| Richard Avison | M | - | - | |
| Peter Smith | M | - | 1 años | |
| Kamil Sebastian Sitarz | M | 38 | 11 años | |
| Ari Brettman | M | 42 |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | 3 años |
| Gerhard Ehninger | M | - |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | 3 años |
| Imke Mulder | F | - | - | |
| Scott Fields | M | 69 | 1 años | |
| Glenn Goddard | M | 53 |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | - |
| Glenn Dourado | M | - | - | |
| Piotr Romanowski | M | - | 5 años | |
| Vatnak Vat-Ho | M | - | 3 años | |
| Olivier Brandicourt | M | 68 |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | - |
| Rafal Chwast | M | - | - | |
| Thomas Turalski | M | - | - | |
| Markus Orchowski | M | - |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | 2 años |
| Tadeusz Wesolowski | M | 72 | - | |
| Christophe Carite | M | - | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 67 | 67.00% |
| Reino Unido | 12 | 12.00% |
| Polonia | 12 | 12.00% |
| Suecia | 9 | 9.00% |
| Bélgica | 1 | 1.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Axel Gaston Glasmacher
- Red Personal